Todd Bazemore

CIK: 0001605767

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KALA

KALA BIO, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

KALA
KALA BIO, Inc.
Oct 22, 2025
Sale(S)
Direct
47.8K shares at avg. $0.83$40K
KALA
KALA BIO, Inc.
Aug 29, 2025
Award(A)
Stock Option (right to buy)
Direct
180K shares-
KALA
KALA BIO, Inc.
Jun 24, 2025
Sale(S)
Direct
4.1K shares at avg. $4.01$16K
KALA
KALA BIO, Inc.
Jun 3, 2025
Sale(S)
Direct
3.4K shares at avg. $3.74$13K
KALA
KALA BIO, Inc.
Mar 7, 2025
Award(A)
Stock Option (right to buy)
Direct
45.2K shares-
KALA
KALA BIO, Inc.
Jan 6, 2025
Sale(S)
Direct
2K shares at avg. $7.63$15K
KALA
KALA BIO, Inc.
Jan 6, 2025
Award(A)
Direct
10.1K shares-

		Type	Shares	Price		Ownership
Oct 22, 2025	KALA KALA BIO, Inc.	Sale(S)	47,768	$0.83	$39,647	Direct
Aug 29, 2025	KALA KALA BIO, Inc.	Award(A) Stock Option (right to buy)	180,000	-	-	Direct
Jun 24, 2025	KALA KALA BIO, Inc.	Sale(S)	4,058	$4.01	$16,273	Direct
Jun 3, 2025	KALA KALA BIO, Inc.	Sale(S)	3,390	$3.74	$12,679	Direct
Mar 7, 2025	KALA KALA BIO, Inc.	Award(A) Stock Option (right to buy)	45,200	-	-	Direct
Jan 6, 2025	KALA KALA BIO, Inc.	Sale(S)	1,993	$7.63	$15,207	Direct
Jan 6, 2025	KALA KALA BIO, Inc.	Award(A)	10,100	-	$0	Direct

1-7 of 7 transactions

About Bazemore Todd

Bazemore Todd (SEC CIK 0001605767) files insider reports with the SEC as Officer of KALA BIO, Inc. (KALA).

Signal8 holds 6 ownership filings by Bazemore Todd, all Form 4s, filed between Jan 7, 2025 and Oct 24, 2025. Those filings report 7 transactions, from Jan 6, 2025 to Oct 22, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Bazemore Todd's filings is in ARLINGTON, MA.

Recent filings by Bazemore Todd

Oct 22, 2025: Open-market sale of KALA shares (Form 4, code S).
Aug 29, 2025: Grant or award of KALA derivative securities (Form 4, code A).
Jun 24, 2025: Open-market sale of KALA shares (Form 4, code S).
Jun 3, 2025: Open-market sale of KALA shares (Form 4, code S).
Mar 7, 2025: Grant or award of KALA derivative securities (Form 4, code A).

Other insiders filing for KALA BIO, Inc. (KALA)

Purdy Brendan P., Director
Posen Hillel D., Director
Minkowitz Avraham, Chief Executive Officer
Colman Yonatan C., Director
Berger Chaim D., Director
Lazar David E., Chief Executive Officer

How to read Form 4 transaction codes